Ortho Regenerative Technologies reported a successful pre-investigational drug meeting with the FDA in February and is now preparing for its rotator cuff phase I/II clinical trial.
The Latest
Here are nine orthopedic surgeons making the news this week.
Fuse Medical, a company focused on orthopedic and spine devices, reported improvements in second quarter earnings.
Amer Samdani, MD, is the chief of surgery for Shriners Hospital for Children – Philadelphia.
In July, orthobiologics company Biogennix hit its best ever month for sales since its formation in 2009.
Biofirma, a subsidiary of IMAC Holdings, received "registered" status by the FDA.
Researchers at the Barrow Neurological Institute in Phoenix are 3D printing replicas of patients' spines to allow surgeons to practice complex procedures, reports Fox 10 Phoenix.
A study published in Stem Cells Translational Medicine found that an injection of human amniotic fluid stem cells can be used to protect the spinal cord of a fetus from myelomeningocele.
In Wichita Falls, Texas in 1971, two general medical officers — Stephen Hochschuler, MD, and Ralph Rashbaum, MD — met each other for the first time while stationed in the U.S. Air Force.
Mosaic Medical Center-Maryville (Mo.) expanded its orthopedic and sports medicine program, according to The Maryville Forum.